oxazoles has been researched along with Shock, Septic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, JW; Jang, CH; Ji, YE; Kang, TB; Koppula, S; Lee, KH; Shim, DW; Shin, HJ | 1 |
| Al Abed, Y; Claesson, M; Cuzzocrea, S; Donia, M; Kim, J; Mangano, K; Mazzon, E; Miljkovic, D; Nicoletti, F; Stojanovic, I; Stosic-Grujicic, S; Wang, M | 1 |
| Quinn, JV; Slotman, GJ | 1 |
3 other study(ies) available for oxazoles and Shock, Septic
| Article | Year |
|---|---|
A novel synthetic derivative of melatonin, 5-hydroxy-2'-isobutyl-streptochlorin (HIS), inhibits inflammatory responses via regulation of TRIF-dependent signaling and inflammasome activation.
Topics: Acute Lung Injury; Adaptor Proteins, Vesicular Transport; Animals; Anti-Inflammatory Agents; Cell Line; Cyclooxygenase 2; Disease Models, Animal; Female; Indoles; Inflammasomes; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Macrophages; Melatonin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitochondria; Nitric Oxide; Oxazoles; Random Allocation; Reactive Oxygen Species; Shock, Septic; Signal Transduction; Tumor Necrosis Factor-alpha | 2015 |
In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models.
Topics: Acetates; Acetylmuramyl-Alanyl-Isoglutamine; Animals; Arthritis, Experimental; CD4-Positive T-Lymphocytes; Cell Proliferation; Cell Survival; Cytokines; Female; I-kappa B Proteins; Immunologic Factors; Leukocytes, Mononuclear; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Mitogen-Activated Protein Kinases; Oxazoles; Phosphorylation; Pleurisy; Shock, Septic; Spleen; Survival Rate | 2007 |
Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
Topics: Aeromonas hydrophila; Animals; Arachidonic Acid; Azepines; Bridged Bicyclo Compounds, Heterocyclic; Eicosanoids; Female; Gram-Negative Bacterial Infections; Heart Diseases; Hemodynamics; Hypertension, Pulmonary; Lipoxygenase Inhibitors; Masoprocol; Oxazoles; Oxygen; Oxygen Consumption; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Shock, Septic; Swine; Thromboxane A2; Triazoles; Tumor Necrosis Factor-alpha | 1999 |